Home Clot risk in Lilly lung-cancer drug raises FDA concerns
 

Keywords :   


Clot risk in Lilly lung-cancer drug raises FDA concerns

2015-07-07 21:33:35| Biotech - Topix.net

Eli Lilly and Co.' s experimental lung cancer drug has raised concerns with U.S. regulators that it may increase patients' risk of suffering potentially deadly blood clots.

Tags: risk drug concerns raises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 EVA 6
23.11 8
23.11SEVENTEEN ALWAYS YOURS Weverse 13
23.11 DX
23.11 No.23/1998
23.11 DVD 9
23.11
23.11 CD His Melody
More »